Effects on α- and β-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study. Science 18. März 2020 ShareTwitterFacebookXingLinkedin First published in John Wiley & Sons Ltd., Diabetes obesity and metabolism on 2017 Apr.Diabetes Obes Metab. 2017 Apr;19(4):489-495. doi:... Read Article
